Biotech Archives - Page 45 of 61 - Life Sciences Times

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

June 10, 2025

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

June 9, 2025

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

THIS WEEK'S STORIES

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

June 6, 2025

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

June 7, 2025

BrainScope Unveils Next-Gen Deep Learning Platform and Expands Board to Advance Brain Health Innovation

June 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Qlaris Bio Advances Fixed-Dose Combination Therapy for Glaucoma Treatment

Bayer and Broad Institute Extend Collaboration to Advance Cardiovascular Therapies

Scipher Medicine Partners with Top-Tier Pharma Company to Advance Precision Medicine in Clinical Trials

Nu-Tek BioSciences Highlights Animal-Free Innovations at BIO International Convention 2025

Emulate Launches AVA Emulation System, Pioneering High-Throughput Organ-Chip Platform to Accelerate Drug Development

Most Read

FDA Expands Approval of MAVYRET® to Include Treatment for Acute Hepatitis C, Offering First-Ever Eight-Week Cure Option

FDA Approves Nuvation Bio’s IBTROZI™ for Advanced ROS1-Positive Lung Cancer

Vivex Biologics Names Dr. Jon E. Block as Chief Clinical Officer to Lead Spine Therapy Trials

DT Research and Homeland Language Services Launch Mobile 5G Telehealth Translation Stations to Bridge Language Gaps in Healthcare

EDITOR PICKS